Wednesday, February 10, 2010, 5:37pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Idenix Pharmaceuticals Inc. (IDIX)

At 5:00AM SGT: 3.00 USD   0.00 (0.00%)  
 MORE ON IDIX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Idenix Pharmaceuticals, Inc. (NGM:IDIX) Delayed quote dataEdit
Last Trade:3.00 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:3.00
Open:N/A
Bid:2.61 x 100
Ask:3.58 x 100
1y Target Est:4.60
Day's Range:N/A - N/A
52wk Range:1.81 - 5.96
Volume:0
Avg Vol (3m):158,146
Market Cap:199.03M
P/E (ttm):N/A
EPS (ttm):-0.93
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add IDIX to Portfolio   Download Data

 HEADLINES 
•Idenix Pharmaceuticals To Present at 12th Annual BIO CEO & Investor Conference
PR Newswire (Tue, Feb 2)
•IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 16)
•Stocks to Watch at Biotech’s Bellwether Conference
at Minyanville.com (Tue, Jan 12)
•Idenix Pharma shares rise on hepatitis study data
AP (Tue, Jan 12)
•Idenix announces positive results from hepatitis C trial
at Reuters (Mon, Jan 11)
•Early-Market Movers: Tuesday Morning, Ballard Power Systems
at Fox Business (Mon, Jan 11)
•Idenix Pharmaceuticals Highlights Progress in Three HCV Programs
PR Newswire (Mon, Jan 11)
•Idenix Pharmaceuticals to Present at the 28th Annual J. P. Morgan Healthcare Conference
PR Newswire (Tue, Jan 5)
•IDENIX PHARMACEUTICALS INC Financials
EDGAR Online Financials (Wed, Nov 4)
•YRC Worldwide, AXT: Early Volume Plays
at TheStreet.com (Fri, Oct 30)
More Headlines for IDIX...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.89
EPS Est (in 2 years) (Dec-10) :-0.73
Avg Rec (current)*:2.2
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases in the United States and Europe.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices